AIM
EXAS

ARK Investment Management’s Exact Sciences EXAS Stock Holding History

ARK Investment Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-800
Closed -$26K – 238
2022
Q3 		$26K Buy
+800
New +$33K ﹤0.01% 245

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

ARK Investment Management's EXAS Position: Q1 2026 in Review

ARK Investment Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 77 shares — an estimated $7.86K sold.

ARK Investment Management first reported a position in EXAS in Q3 2020 and held it in 22 quarters. The position peaked at $1.33B in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • ARK Investment Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • ARK Investment Management sold 77 Exact Sciences shares in Q1 2026, an estimated $7.86K.
  • ARK Investment Management first reported a position in Exact Sciences in Q3 2020 and held it in 22 quarters.
  • ARK Investment Management's Exact Sciences position peaked at $1.33B in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on ARK Investment Management's 13F filing for Q1 2026, filed 12 May 2026.